$MD News

Jefferies Downgrades Pediatrix Medical Group (MD)

Jefferies Downgrades Pediatrix Medical Group to Hold, Raises Price Target to $28

Pediatrix Medical Group (NYSE:MD): A Value Stock with a Clear Margin of Safety

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $28

Pediatrix Medical Group, Inc. (MD) Q2 2026 Earnings Call Transcript

Pediatrix Medical Group (NYSE:MD) Q2 EPS Beats Expectations, but Revenue Falls Just Short

Full Transcript: Pediatrix Medical Group Q2 2026 Earnings Call

Pediatrix Medical Group Q2 Adj. EPS $0.63 Beats $0.59 Estimate, Sales $487.783M Beat $478.449M Estimate

Pediatrix Medical Group (NYSE:MD): A Decent Value Stock at a Discount

Pediatrix Reports Q2 Payor Mix Remains Stable, No Material Changes In Net Revenue Trends; Reaffirms FY26 Adj EBITDA Outlook Of $280M-$300M

Truist Securities Maintains Hold on Pediatrix Medical Group, Raises Price Target to $28

Pediatrix Medical Group Inc (NYSE:MD): A Decent Value Play in a Bull Market

Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology

Pediatrix Medical Group Publishes New Research On Probiotic Use And Necrotizing Enterocolitis In Preterm Infants

Q1 Earnings Roundup: Pediatrix Medical Group (NYSE:MD) And The Rest Of The Healthcare Providers & Services Segment

Assessing Pediatrix Medical Group (MD) Valuation As Shares Show Mixed Short Term Momentum

Does Pediatrix Medical Group (MD) Stock Look Better After Q1 Report?

Pediatrix Medical Group Inc (NYSE:MD) Offers a Compelling Value Proposition with Strong Fundamentals

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

How Investors Are Reacting To Pediatrix Medical Group (MD) Pricing‑Driven Earnings Outperformance And Margin Gains